Lv31
390 积分 2025-07-16 加入
Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus
3天前
已完结
Plasmacytoid dendritic cells alleviate atopic dermatitis by suppressing Th2 inflammation via the IFN-α/IFNAR1 pathway
4天前
已完结
Persistence of mature dendritic cells, T H 2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade
4天前
已完结
Update on the pathophysiology and treatment of primary Sjögren syndrome
1个月前
已完结
Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity
1个月前
已完结
Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome
1个月前
已完结
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus
1个月前
已完结
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
1个月前
已完结
Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort
1个月前
已关闭
Sjögren's Syndrome: Current Insights into Pathogenesis, Diagnosis and Treatment
1个月前
已关闭
皖公网安备34019202002308
